IT1319665B1 - CORTICOSTEROID ADDUCTS WITH NATURAL POLYSACCHARIDIC POLYMERS. - Google Patents

CORTICOSTEROID ADDUCTS WITH NATURAL POLYSACCHARIDIC POLYMERS.

Info

Publication number
IT1319665B1
IT1319665B1 IT2000MI002477A ITMI20002477A IT1319665B1 IT 1319665 B1 IT1319665 B1 IT 1319665B1 IT 2000MI002477 A IT2000MI002477 A IT 2000MI002477A IT MI20002477 A ITMI20002477 A IT MI20002477A IT 1319665 B1 IT1319665 B1 IT 1319665B1
Authority
IT
Italy
Prior art keywords
corticosteroid
adducts
natural
polysaccharidic
polymers
Prior art date
Application number
IT2000MI002477A
Other languages
Italian (it)
Inventor
Piergiorgio Anzaghi
Rosanna Stefli
Original Assignee
Pharma Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Biotech Ltd filed Critical Pharma Biotech Ltd
Priority to IT2000MI002477A priority Critical patent/IT1319665B1/en
Priority to PCT/IB2001/002170 priority patent/WO2002040029A2/en
Priority to AU2002212630A priority patent/AU2002212630A1/en
Publication of ITMI20002477A1 publication Critical patent/ITMI20002477A1/en
Application granted granted Critical
Publication of IT1319665B1 publication Critical patent/IT1319665B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IT2000MI002477A 2000-11-17 2000-11-17 CORTICOSTEROID ADDUCTS WITH NATURAL POLYSACCHARIDIC POLYMERS. IT1319665B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2000MI002477A IT1319665B1 (en) 2000-11-17 2000-11-17 CORTICOSTEROID ADDUCTS WITH NATURAL POLYSACCHARIDIC POLYMERS.
PCT/IB2001/002170 WO2002040029A2 (en) 2000-11-17 2001-11-16 Corticosteroids adducts with natural polysaccharide polymers
AU2002212630A AU2002212630A1 (en) 2000-11-17 2001-11-16 Corticosteroids adducts with natural polysaccharide polymers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI002477A IT1319665B1 (en) 2000-11-17 2000-11-17 CORTICOSTEROID ADDUCTS WITH NATURAL POLYSACCHARIDIC POLYMERS.

Publications (2)

Publication Number Publication Date
ITMI20002477A1 ITMI20002477A1 (en) 2002-05-17
IT1319665B1 true IT1319665B1 (en) 2003-10-23

Family

ID=11446118

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI002477A IT1319665B1 (en) 2000-11-17 2000-11-17 CORTICOSTEROID ADDUCTS WITH NATURAL POLYSACCHARIDIC POLYMERS.

Country Status (3)

Country Link
AU (1) AU2002212630A1 (en)
IT (1) IT1319665B1 (en)
WO (1) WO2002040029A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032054A1 (en) 2003-10-22 2005-04-23 Monteres S R L PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUSPENSIONS TO BE INHALED.
CN103705470B (en) * 2014-01-06 2015-06-17 南通大学 Methylprednisolone-loading nanoparticles as well as preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904296D0 (en) * 1989-12-21 1989-12-21 Pharmacia Ab TRANSDERMAL SYSTEM
DE563249T1 (en) * 1990-12-19 1994-03-03 Advanced Magnetics Inc TARGETING THERAPEUTIC AGENTS BY USING POLYSACCHARIDES.
JP2920611B2 (en) * 1995-12-11 1999-07-19 株式会社シーエーシー Topical treatment for dermatitis

Also Published As

Publication number Publication date
WO2002040029A3 (en) 2002-10-31
ITMI20002477A1 (en) 2002-05-17
AU2002212630A1 (en) 2002-05-27
WO2002040029A2 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
MX242679B (en) INSECTED ANTRANILAMIDS.
FI20000004A0 (en) Flavonoidilääke ...
MA25499A1 (en) CONTACTOR-CIRCUIT-BREAKER.
IT1317833B1 (en) THERMO-PROCESSABLE FLUORINATED POLYMERS.
ITBO990359A0 (en) ELECTROSPINDLE.
CH695519A5 (en) Sperrstromthyristor.
DE50105246D1 (en) WINKEL- BZW. SCHRÄGBOHR SETUP
ITBO990358A0 (en) ELECTROSPINDLE.
IT1319665B1 (en) CORTICOSTEROID ADDUCTS WITH NATURAL POLYSACCHARIDIC POLYMERS.
NL1011488A1 (en) Headphone-microphone combination.
IT1307020B1 (en) N-NITRO-DINITRO-ANYLENE N-DENITRATION PROCEDURE IN PHASEOMOGENEOUS.
IT1320340B1 (en) EQUIPMENT COMPLEX.
ITSS990004V0 (en) PYRAMID - REMEMBER.
ES1042242Y (en) FILE CABINET.
FI20000834A (en) The telecommunications system
BR8001582Y1 (en) provision introduced into the building.
ITNA20000008V0 (en) CINGIBICCHIERE PUPAZZO WITH PLACEKEEPER FUNCTION.
ES1045464Y (en) ARTIFICIAL TREE.
ES1047381Y (en) EMPOTRABLE ELECTRIC SWITCH-SWITCH.
ITBO20000359A0 (en) SPEAKER.
ES1046605Y (en) DIGITAL REPAIR CABINET.
ITLI990003V0 (en) WALLET.
IT247637Y1 (en) Tritapepe.
ES1043620Y (en) URNA-COLUMBARIO.
ES1044580Y (en) HUMIDIFIER-PHYTOSANITARY.